{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "A total of 121 eligible children aged 13\u2009years, who were scheduled for transthoracic echocardiography were randomized into three groups."
      },
      "Participants": {
        "score": 1,
        "evidence": "A total of 121 eligible children aged 13\u2009years, who were scheduled for transthoracic echocardiography were randomized into three groups."
      },
      "Intervention": {
        "score": 2,
        "evidence": "They were treated with intranasal dexmedetomidine 1\u2009mcg.kg \u22121 + esketamine 0.5\u2009mg.kg \u22121 (group S1), dexmedetomidine 1\u2009mcg.kg \u22121 + esketamine 1\u2009mg.kg \u22121 (group S2), or dexmedetomidine 1\u2009mcg.kg \u22121 + esketamine 1.5\u2009mg.kg \u22121 (group S3)."
      },
      "Objective": {
        "score": 1,
        "evidence": "In this study, we compared the different doses of intranasal esketamine combined with dexmedetomidine for sedation during transthoracic echocardiography in toddlers."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the success rate of sedation, other outcomes included HR, SpO 2 , onset time, wake-up time, and adverse effects."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "A total of 121 eligible children aged 13\u2009years, who were scheduled for transthoracic echocardiography were randomized into three groups."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 121 eligible children aged 13\u2009years, who were scheduled for transthoracic echocardiography were randomized into three groups."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The success rate of sedation was significantly higher in groups S2 (85.4%) and S3 (87.5%) than ingroup S1 (60%) ( p =\u20090.004)."
      },
      "Harms": {
        "score": 1,
        "evidence": "However, there were no differences in the wake-up time or adverse effects among the three groups."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Clinical trial registration number: ChiCTR2200060976, 2022/06/14 (trail from August 2022 to January 2023)"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}